Inhalation

INH1024

Issue link: https://www.e-digitaleditions.com/i/1527415

Contents of this Issue

Navigation

Page 35 of 38

This section is presented as a service to Inhalation’s readers. Content is provided by Inhalation’s advertisers. No product endorsement or preference is intended. 34 OctOber 2024 Inhalation WHITE PAPERS AND WEBINARS These white papers and webinars from Inhalation's advertisers are presented as a service to readers. Content is provided by the companies listed. No product endorsement or preference is intended. Copley Scientific Improving Performance in Inhaled Therapeutics Copley experts Dr. Clair Brooks and Matthew Fenn discuss how patient behavior can impact efficacy of OIPs and what can be done to address this issue. www.copleyscientific.com Qualicaps Research and findings of Qualicaps ® R&D departments, in close collaboration with Academia contribute to our improved understanding of capsules' performance for use in dry powder inhalers. www.qualicaps.com Intertek Learn more about the advantages, disadvantages and challenges associated with repurposing existing active pharmaceutical ingredients for respiratory delivery with our article "Repurposing Drugs for Respiratory Delivery." www.intertek.com S-Matrix Use the link below to see the S-Matrix Fusion Inhaler Testing (FIT) Software Platform web page where you can access important information regarding the ISO 27427 and USP <1604> Guidances. www.smatrix.com MSP, a Division of TSI ® Better in vivo prediction from OINDP testing is needed due to complex interactions and limited in vitro test relevance, especially for demonstrating bioequivalence. Learn more. www.tsi.com

Articles in this issue

Links on this page

view archives of Inhalation - INH1024